Stories

Discovery

May 26, 2026

Pushing the prostate cancer treatment frontier: Radioligand therapy and beyond

Radioligand therapy (RLT) has helped change what’s possible in prostate cancer treatment, but Novartis continues to work on the next wave of innovations to bring new options to patients.

Discovery

People and Culture

Apr 29, 2026

Novartis partners with Special Olympics World Winter Games Switzerland 2029

Novartis partners with the Special Olympics to support neuro ‑ inclusion and build environments where everyone belongs.

People and Culture

People and Culture

Apr 28, 2026

Full Circle: A Story of Growth, Purpose and Coming Home to Novartis

Polly Cooper, Clinical Development Function Head, UK

People and Culture

Apr 10, 2026

New long term social impact and sustainability targets

Novartis has announced new long-term Social Impact & Sustainability (SI&S) targets and goals, reinforcing our commitment to go beyond breakthroughs to maximize the impact of our medicines to support inclusive, resilient healthcare systems worldwide.

Access to Healthcare

Mar 31, 2026

Working with communities to close gaps in heart disease and cancer care

Our innovations matter only when they reach the people who need them. Yet millions live with heart disease or cancer without knowing it or have limited access to care – especially those in low-income, rural or other hard-to-reach communities.

Access to Healthcare

Patient Perspectives

Mar 30, 2026

Managing Quality of Life with CML

How shared decision-making can support living well from the start with chronic myeloid leukemia

Patient Perspectives

People and Culture

Mar 18, 2026

Building the Future: Novartis Innovation Lab - AI, Game Studio, XR & Emerging Tech

The leaders behind the Novartis Innovation Lab share how they are leveraging emerging technologies to win for patients.

People and Culture

From Our Labs

Mar 10, 2026

Bringing proteins together to take cancer apart

A Q&A with Jake Haling, Head of Oncology Drug Discovery in San Diego, on induced proximity and how it could open new paths to treat cancer.

From Our Labs

People and Culture

Mar 5, 2026

Turning personal experience into purpose-driven careers

What drives someone to dedicate their career to reimagining medicine? Three women at Novartis share their deeply personal and unique stories.

People and Culture

People and Culture

Mar 6, 2026

Supercharging R&D: How AI helps us to bring medicines to patients faster

Max leads AI innovation in pharmaceutical development at Novartis. His story reflects how cutting-edge technology is combined with human expertise for meaningful impact.

People and Culture

Discovery

Feb 23, 2026

Breaking ground in Global Health

Manju Ujjini, Head of Lead Discovery for our Global Health Biomedical Research group, discusses what’s next for his team in drug discovery

Discovery

Feb 9, 2026

Victor Bulto and Thierry Diagana named to 2026 TIME100 Health List

Novartis is proud to share that TIME has recognized Victor Bultó and Thierry Diagana among the most influential people shaping the future of health. Learn more about what drives our honorees.